The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

Infant nutrition firm ByHeart has secured $95 million in financing to support its US commercial launch and innovation pipeline. The company also announced it had completed its full end-to-end domestic manufacturing chain, with new manufacturing facilities in Portland, Oregon, and Allerton, Iowa. The new sites will enable the brand to expand production of its breakthrough formula to meet the needs of the infant nutrition market. ByHeart, a ‘Clean Label Project Certified’ brand, says it is the “only new infant formula company” to open two new domestic facilities since the national infant formula shortage, helping to fortify the country's infant nutrition supply chain and mitigate the risk of future formula shortages. While some new US formula brands rely on external parties to complete steps in the production process, ByHeart's end-to-end manufacturing allows for full control, ensuring all aspects of production are held to rigorous quality standards. Incorporating the latest in breast milk science, ByHeart brings babies clinically proven benefits such as easier digestion, more efficient weight gain and enhanced nutrient absorption. ByHeart claims to be the first infant formula company to launch a breast milk-equivalent. Ron Belldegrun, CEO and co-founder of ByHeart, said: "ByHeart's foundation was built on a culture of innovation – incorporating clinical trials, highest quality ingredients, advanced nutrition science and a proprietary recipe – from day one. We are committed to doing better for babies and their parents, and that means continued investments into end-to-end manufacturing, scientific advancement and meaningful innovation in an industry that so desperately needed it." Amy Schulman, ByHeart's chair of the board and managing partner at investor Polaris Partners, added: "Polaris is delighted to continue to support the expansion of ByHeart's infant-first mission. In the long-stagnant infant formula space, ByHeart's evidence-based approach drives innovation to benefit the health and wellness of babies and families. Our investors and team recognise the responsibility we have to provide the highest standard of nutrition, crafted with scientific precision and the utmost care."